A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
15 Jan 2021	Submitted	Original manuscript
21 Jan 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
24 Jan 2021	Editorially accepted
5 Feb 2021	Article published	10.1186/s13063-021-05072-4

Back to article page